B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Uprosertib

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Uprosertib, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

afuresertib
11 shared targets
capivasertib
13 shared targets
y
10 shared targets
gsk
6 shared targets
hydroxyfasudil
14 shared targets · score 27.5
gsk
17 shared targets
baricitinib
8 shared targets
fasudil
7 shared targets
pf
17 shared targets
ripasudil
6 shared targets
Loading evidence profile...

This evidence profile for Uprosertib is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.